Radiopharm TheranosticsRADX
13F holders, Q4 2025 (December 31)11holders +7
7new positions
0sold out
$0.07avg. 13F price*
At the end of Q4 2025, 11 institutions reported holding Radiopharm Theranostics Ltd. (RADX) in their 13F filings, up 7 from Q3 2025. 7 opened new positions and 0 sold out. The largest holders were HSBC Holdings PLC ($1.0M), Silverarc Capital Management, LLC ($978K) and Stonepine Capital Management, LLC ($851K).
- Company
- Radiopharm Theranostics Ltd.
- CUSIP
- 75041J101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.1M |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 51,230,985 shares bought and 3,914 shares sold, net +51,227,071 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| HSBC Holdings PLC | 0.00% | New | 191,624 | $1.0M |
| Silverarc Capital Management, LLC | 0.14% | No change | 187,406 | $978K |
| Stonepine Capital Management, LLC | 0.67% | New | 51,000,000 | $851K |
| Regal Partners Ltd | 0.03% | No change | 90,909 | $475K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 16,000 | $84K |
| Virtu Financial LLC | 0.00% | New | 14,591 | $76K |
| Jane Street Group, LLC | 0.00% | New | 14,469 | $76K |
| UBS Group AG | 0.00% | Reduce -21.5% | 14,277 | $75K |
| Marex Group Ltd | 0.00% | New | 10,285 | $54K |
| Strategic Wealth Partners, Ltd. | 0.00% | New | 10 | $52 |
| Rhumbline Advisers | 0.00% | New | 6 | $31 |
"% of holder's portfolio" is RADX's weight in each manager's 13F, not the share of Radiopharm Theranostics Ltd. the manager owns.